BOSTON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Snyk, the leader in developer security, and Orca Security, the leader in agentless cloud security, today unveiled a new strategic partnership. The first ...
If approved, Orca-T would be the first allogeneic T-cell immunotherapy for the treatment of hematological malignancies including acute myeloid leukemia, acute lymphoblastic leukemia and ...
PORTLAND, Ore.--(BUSINESS WIRE)--Orca Security, the pioneer of agentless cloud security, today announced new application security capabilities that unify security, DevOps and development teams to ...
OS2000 IO-Link Communications Transceiver Improves Intelligence and Productivity for Industrial Applications MILPITAS, Calif., Nov. 6, 2024 /PRNewswire/ -- Orca Semiconductor today announced the ...
Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses findings from the phase 3 Precision-T trial of Orca-T in acute leukemia and ...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results